ARCHIVED · 3 LEFT · 7 CENTER · 0 RIGHT · Aug 27, 1:19 AM
ABC News - Business and The Columbian (Vancouver WA) describe the same event in different terms.
30-SECOND READ
WORDING GAP
10 sources · 2 bias buckets · Medium confidence
Still Watching. The left frames it as "FDA approves new pancreatic cancer drug that could extend patients' lives". The center frames it as "US drug agency approves breakthrough treatment for pancreatic cancer".
SOURCE MAP TIMELINE
Aug 26, 10:00 PM: WBIR10 (Tegna, Knoxville) joined the source map.
Aug 26, 10:02 PM: BBC World joined the source map.
Aug 26, 10:18 PM: ABC News - Business joined the source map.
Aug 26, 10:31 PM: The Columbian (Vancouver WA) joined the source map.
Now: Wording Gap is 58/99 and story health is live match · 15 sources · 2 buckets · comparable news format.
ARCHIVED SOURCES
The drug uses a new approach to block a protein that fuels tumor growth. Patients taking the drug nearly doubled their survival time in a company study.
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer.
Patients taking the first-of-a-kind pill, called daraxonrasib, lived for a median of 13.2 months compared with 6.7 months for chemotherapy recipients, studies showed.
The Food and Drug Administration (FDA) on Wednesday approved a treatment for advanced pancreatic cancer, offering new life-extending care for patients with one of the most aggressive forms...
The US FDA on Wednesday approved Revolution Medicines' Rasonque for advanced pancreatic cancer, opening a new treatment option for patients with metastatic disease. A large trial found the...
Jerrty Simonson is shown at his home earlier this year in West Valley City, Utah. Simonson has been taking daraxsonrasib as part of a clinical trial for nearly four years. His cancer is no...
In a late-stage study, Rev Med’s Rasonque helped subjects live to 13 months, nearly twice as long as those who only received chemotherapy.
WASHINGTON — The Food and Drug Administration on Wednesday approved a groundbreaking new drug for advanced pancreatic cancer, offering U.S. patients a more effective treatment against one o...
U.S. health officials have approved a groundbreaking pancreatic cancer drug that offers a new approach to treating the deadly form of cancer
Experts have hailed the drug, daraxonrasib, as a game changer for one of the world's deadliest cancers.